These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2713368)

  • 1. Crystallization of isoelectrically homogeneous cholera toxin.
    Spangler BD; Westbrook EM
    Biochemistry; 1989 Feb; 28(3):1333-40. PubMed ID: 2713368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallization and preliminary x-ray diffraction study of cholera toxin B-subunit.
    Maulik PR; Reed RA; Shipley GG
    J Biol Chem; 1988 Jul; 263(19):9499-501. PubMed ID: 3379076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine P2 myelin basic protein crystallizes in three different forms.
    Sedzik J; Bergfors T; Jones TA; Weise M
    J Neurochem; 1988 Jun; 50(6):1908-13. PubMed ID: 2453613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and purification of cholera toxin.
    Mekalanos JJ
    Methods Enzymol; 1988; 165():169-75. PubMed ID: 3231099
    [No Abstract]   [Full Text] [Related]  

  • 5. A 9 A two-dimensional projected structure of cholera toxin B-subunit-GM1 complexes determined by electron crystallography.
    Mosser G; Mallouh V; Brisson A
    J Mol Biol; 1992 Jul; 226(1):23-8. PubMed ID: 1619652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polypeptide chain fold in tyrosine phenol-lyase, a pyridoxal-5'-phosphate-dependent enzyme.
    Antson AA; Strokopytov BV; Murshudov GN; Isupov MN; Harutyunyan EH; Demidkina TV; Vassylyev DG; Dauter Z; Terry H; Wilson KS
    FEBS Lett; 1992 May; 302(3):256-60. PubMed ID: 1601133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallization of diphtheria toxin.
    Fujii G; Choe SH; Bennett MJ; Eisenberg D
    J Mol Biol; 1991 Dec; 222(4):861-4. PubMed ID: 1762153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of cholera toxin and its subunits: new methods of preparation and the use of hypertoxinogenic mutants.
    Mekalanos JJ; Collier RJ; Romig WR
    Infect Immun; 1978 May; 20(2):552-8. PubMed ID: 669812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholera toxin crystals suitable for x-ray diffraction.
    Sigler PB; Dryan ME; Kiuefer HC; Finkelstein RA
    Science; 1977 Sep; 197(4310):1277-9. PubMed ID: 897666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-dimensional crystals of cholera toxin B-subunit-receptor complexes: projected structure at 17-A resolution.
    Ludwig DS; Ribi HO; Schoolnik GK; Kornberg RD
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8585-8. PubMed ID: 3464971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal parameters and molecular replacement of an anticholera toxin peptide complex.
    Shoham M; Proctor P; Hughes D; Baldwin ET
    Proteins; 1991; 11(3):218-22. PubMed ID: 1749774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2.4 A crystal structure of cholera toxin B subunit pentamer: choleragenoid.
    Zhang RG; Westbrook ML; Westbrook EM; Scott DL; Otwinowski Z; Maulik PR; Reed RA; Shipley GG
    J Mol Biol; 1995 Aug; 251(4):550-62. PubMed ID: 7658472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization of the HigBA2 toxin-antitoxin complex from Vibrio cholerae.
    Hadži S; Garcia-Pino A; Martinez-Rodriguez S; Verschueren K; Christensen-Dalsgaard M; Gerdes K; Lah J; Loris R
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Sep; 69(Pt 9):1052-9. PubMed ID: 23989162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallization of Pichia pastoris lysyl oxidase.
    Lee M; Willingham K; Langley D; Maher MJ; Cohen AE; Ellis PJ; Kuchar JA; Dooley DM; Freeman HC; Guss JM
    Acta Crystallogr D Biol Crystallogr; 2002 Dec; 58(Pt 12):2177-9. PubMed ID: 12454493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of concanavalin A at 4.25-ångström resolution.
    Hardman KD; Wood MK; Schiffer M; Edmundson AB; Ainsworth CF
    Proc Natl Acad Sci U S A; 1971 Jul; 68(7):1393-7. PubMed ID: 5283926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity purification of recombinant cholera toxin B subunit oligomer expressed in Bacillus brevis for potential human use as a mucosal adjuvant.
    Yasuda Y; Matano K; Asai T; Tochikubo K
    FEMS Immunol Med Microbiol; 1998 Apr; 20(4):311-8. PubMed ID: 9626936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide.
    Merritt EA; Sarfaty S; van den Akker F; L'Hoir C; Martial JA; Hol WG
    Protein Sci; 1994 Feb; 3(2):166-75. PubMed ID: 8003954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new crystal form of ricin-OR.
    Chang WR; Chen LQ; Rose J; Wei CH; Abrams L; Sax M; Wang BC
    Eur J Biochem; 1989 Mar; 180(2):327-8. PubMed ID: 2924767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of high-specific-activity subunits of cholera toxin by reversed-phase high-performance liquid chromatography.
    Pearson SD; Dixon JD; Nothwehr SF; Kurosky A
    J Chromatogr; 1986 May; 359():413-21. PubMed ID: 3016001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystallization and subunit structure of canine myeloperoxidase.
    Fenna RE
    J Mol Biol; 1987 Aug; 196(4):919-25. PubMed ID: 2824790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.